Form 4: IN8BIO Director Corinne Epperly Acquires Stock Options

Director Corinne Epperly of IN8BIO, INC. reports acquisition of stock options.

Summary

• On June 12, 2024, Corinne Epperly, a director of IN8BIO, INC. acquired stock options to purchase 33,650 shares of common stock at an exercise price of $1.47 per share.
• The options vest in equal monthly installments starting July 12, 2024, and will be fully vested by the date of the company's next annual meeting of stockholders, contingent upon continued service.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition, which doesn't inherently indicate positive or negative sentiment.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The options will be fully vested by the date of the company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the compensation and equity ownership of company directors.

Stakeholder Impact

• The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment, as it may signal confidence in the company's future.

Key Dates